A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

  • STATUS
    Recruiting
  • participants needed
    1088
  • sponsor
    Urovant Sciences GmbH
Send
Updated on 22 September 2023
See if I qualify
cancer
benign prostatic hypertrophy
alpha blocker
nocturia
micturition chart
vibegron

Summary

This study will assess the efficacy of vibegron compared with placebo in men with overactive bladder (OAB) symptoms on pharmacological therapy for benign prostatic hyperplasia (BPH) as defined by micturition and urgency episodes.

Details
Condition Overactive Bladder
Treatment Placebo, vibegron
Clinical Study IdentifierNCT03902080
SponsorUrovant Sciences GmbH
Last Modified on22 September 2023

Similar trials to consider

Browse trials for

cancer
benign prostatic hypertrophy
alpha blocker
nocturia
micturition chart
vibegron

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name
Edit Delete

Added by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note